EMEA-000311-PIP01-08-M04
Key facts
Invented name |
Stelara
|
Active substance |
Ustekinumab
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/0003/2016
|
PIP number |
EMEA-000311-PIP01-08-M04
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of chronic plaque psoriasis
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Janssen-Cilag International NV
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000311-PIP01-08-M04
|
Compliance opinion date |
29/05/2019
|
Compliance outcome |
positive
|